Marc Roth (@MarcRothMD) profile picture

Marc Roth

@MarcRothMD

GI medical oncologist at Saint Luke’s Cancer Institute in KCMO. Husband, father, dog dad, Chiefs fan, KU & Vandy alum. Tweets are my own.

 Kansas City, KS
Joined November 2019
  • Tweets66
  • Following173
  • Followers343
22Media
Photo by Marc Roth (@MarcRothMD)Photo by Marc Roth (@MarcRothMD)Photo by Marc Roth (@MarcRothMD)Photo by Marc Roth (@MarcRothMD)Photo by Marc Roth (@MarcRothMD)Photo by Marc Roth (@MarcRothMD)Photo by Marc Roth (@MarcRothMD)Photo by Marc Roth (@MarcRothMD)Photo by Marc Roth (@MarcRothMD)Photo by Marc Roth (@MarcRothMD)
Marc Roth retweeted
Binaytara (@binaytara) profile picture
Binaytara
@binaytara8 Mar 2025
We welcome 👏 @MarcRothMD from @SLCI_KC, @cancerkc from @HCAMidwest, and Dr. Manidhar Lekkala from @KUCancerCenter to tackle the topic of #precisiononcology in #GICancer at #KansasPO25. Session Chair: @anup_kasi from @KUCancerCenter. 🌟 Visit education.binayfoundation.or… for more upcoming CME conferences! #MedTwitter #MedX #MedEd
Image from Binaytara (@binaytara)
1
3
333
Vanderbilt dim sum at #GI25 is always a highlight—we’ve expanded to two tables! Best GI onc team #GI25 @jordanberlin5 @CathyEngMD @drlauragoff @CardinMD @HeumannThatcher @ChrisCannMD
Image from Kristen Ciombor (@KristenCiombor)
Image from Kristen Ciombor (@KristenCiombor)
2
2
60
2,400
Our correspondence is now available on @TheLancet! Differences in HCC etiology may contribute to the positive result of camrelizumab plus rivoceranib in CARES-310 trial, in contrast to other IO+TKI trials. Thank you @MarcRothMD @SLCI_KC for the support. thelancet.com/journals/lance…
Combination strategies in advanced hepatocellular carcinoma: the CARES-310 trial

Combination strategies in advanced hepatocellular carcinoma: the CARES-310 trial

We read with keen interest the positive results of the CARES-310 study by Shukui Qin and colleagues,1 which compared camrelizumab plus rivoceranib to sorafenib as the first-line treatment in advanced...

thelancet.com
2
3
18
1,349
We extend a stadium-sized thank you to all who joined us for KC Kicks Cancer night with @thekccurrent. We rallied together for an incredibly important cause—raising awareness for preventive cancer screenings and showing support for our loved ones affected by this disease. ⚽️ 💪
Image from Saint Luke's (@saintlukeskc)
Image from Saint Luke's (@saintlukeskc)
Image from Saint Luke's (@saintlukeskc)
Image from Saint Luke's (@saintlukeskc)
1
6
685
NeoAegis study update for #esophageal CA as presented by Dr. Lowery demonstrating ⬆️ path CR with CROSS regimen but NS in 3 yrs OS. #ascogi23 #CancerResearch #cancer #ClinicalTrials
4
1
14
3,035
A positive trial in later line #gastroesophageal is always an accomplishment. INTEGRATE IIa meets primary OS endpoint. @OncLive #GI23
Image from Sam Klempner (@KlempnerSam)
Image from Sam Klempner (@KlempnerSam)
Image from Sam Klempner (@KlempnerSam)
5
15
4
67
15,215
It's official. @VUMCHemOnc fellows are awesome. Congrats @BGriebMD @DDorand_Jr @YuWeiChenMD on ASCO YIA this year. Will sit proudly in the audience to watch them receive the awards
5
1
24
Servier Announces FDA Approval of TIBSOVO® (ivosidenib tablets) in IDH1-Mutated Cholangiocarcinoma prn.to/3sLfj2H
Servier Announces FDA Approval of TIBSOVO® (ivosidenib tablets) in IDH1-Mutated Cholangiocarcinoma

Servier Announces FDA Approval of TIBSOVO® (ivosidenib tablets) in IDH1-Mutated Cholangiocarcinoma

/PRNewswire/ -- Servier Pharmaceuticals, a growing leader in oncology committed to bringing the promise of tomorrow to the patients we serve, announced today...

prnewswire.com
4
1
22
A randomized phase III study of immune checkpoint inhibition with chemotherapy in treatment-naive metastatic anal #cancer patients: A trial of the ECOG-ACRIN cancer research group (EA2176). ascopubs.org/doi/abs/10.1200… @MarcRoth11 @VUMC_Cancer #ASCO21 #Immunotherapy @ASCO #ancsm
A randomized phase III study of immune checkpoint inhibition with chemotherapy in treatment-naive...

A randomized phase III study of immune checkpoint inhibition with chemotherapy in treatment-naive...

TPS3614Background: Anal cancer is growing in annual incidence globally and human papillomavirus (HPV) remains the predominant risk factor underlying its development. Due to its relative rarity,...

ascopubs.org
3
9
Excited to share: Analysis reveals macrophages associated with kidney cancer recurrence news.vumc.org/2021/05/24/ana… via @vumchealth @VUMC_Medicine @VUMC_Cancer @ScottHaake @MarcRoth11 @brian_rini Everything in cancer is suddenly coming up #Macrophages pubmed.ncbi.nlm.nih.gov/3401…
Analysis reveals macrophages associated with kidney cancer recurrence

Analysis reveals macrophages associated with kidney cancer recurrence

A white blood cell, the TREM2/APOE/C1Q-positive macrophage, has been identified as a potential biomarker to predict recurrence of the most common type of kidney cancer and as a possible target for...

news.vumc.org
1
1
22
One thing you must master to be an effective doctor is never taught in medical school. It builds trust and bonds patients to their doctors. It opens the door for honesty and real talk. You must master: Authenticity. 1/21
11
105
25
446
Virtual Run/Walk for MDS, help raise $, & honor retirement of beloved VA/VUMC Prof. Dr. Steven Brandt. Team: Brandt Pluripotent Power Walkers! Goal: $10K. 10/17/2020 9-11AM. Raise $: app.mobilecause.com/vf/MDSNA… TXT 71777 & then txt MDSNASHVILLE12 #MDS #TeamBRANDT #VUMC #Fellows
Image from Laura Van Metre Baum (@LauraVanBaum)
2
3
Started @VUMC_Cancer #hematology #oncology #Fellowship interviewsI💙the enthusiasm to #MakeADifference! youtube.com/watch?v=fVJ4kTl4… Proud to be part of this team! @VUMChealth @jillgilbert15 @KimrynRathmell @christine_lovly @benhopark @jordanberlin5 @nanudasmd @MarcRoth11 #mentoring
VUMC Hematology Oncology Fellowship

VUMC Hematology Oncology Fellowship

Training the Next Generation of World Leaders - For more informatio...

youtube.com
4
1
19
Excited to welcome the new @VUMCHemOnc fellows! @VUMC_Cancer @benhopark @KimrynRathmell @MarcRoth11 @drlauragoff @HornLeora @CardinMD @christine_lovly @jordanberlin5 @RajivAgarwalMD @nanudasmd @VKeedySarcomaMD @NBDavisMD @ejdavis25 @ChrisCannMD @ancellkk @brian_rini @patrickhu
Image from Brian Grieb MD, PhD (@BGriebMD)
4
10
2
49
Load more